Coldstream Capital Management Inc. cut its stake in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 2.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 16,799 shares of the medical equipment provider’s stock after selling 412 shares […]
Royal Bank of Canada reiterated their outperform rating on shares of Boston Scientific (NYSE:BSX – Free Report) in a research note issued to investors on Tuesday morning, Benzinga reports. They currently have a $67.00 target price on the medical equipment provider’s stock. A number of other research firms have also weighed in on BSX. Canaccord […]
Boston Scientific Co. (NYSE:BSX – Get Free Report) EVP Joseph Michael Fitzgerald sold 11,660 shares of the company’s stock in a transaction dated Friday, January 12th. The stock was sold at an average price of $60.00, for a total transaction of $699,600.00. Following the completion of the transaction, the executive vice president now owns 173,472 […]
Wealthfront Advisers LLC lifted its holdings in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 7.1% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 88,886 shares of the medical equipment provider’s stock after purchasing an additional 5,887 shares during […]
Kornitzer Capital Management Inc. KS grew its stake in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 1.2% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 326,016 shares of the medical equipment provider’s stock after buying an additional 3,975 shares during the […]